Jessica Coates

[BHF PROTECT-TAVI @bhfprotect_tavi]

The temperature is rising...and so is our recruitment! #BHFPROTECTTAVI has recruited its 5000th participant! Thank you to all of our participating sites, this is amazing 🥳🎉

[Shawn Wacasey @shawnwacasey]

@FOXSoccer Ref thinks this is rec soccer. Wants girl to hug it out. This ref needs to never ref a world cup match again. Terrible.

[Jessica Coates @Jessica_BSCI]

Did you know that almost two-thirds (64%) of women who die suddenly of coronary heart disease have no previous symptoms?

Today we celebrate Wear Red Day globally to bring awareness to devastating Cardiovascular Diseases and the ways we can prevent them.

#HeartMonth #GoRedBSC

[BostonSci Cardiology @BSCCardiology]

You’re invited! Join us for a #PROTECTEDTAVR webinar on Monday, November 14, 3-4 pm CST. Drs. @SamHorrMD and @KendraGrubb will discuss stroke in #TAVR, the role and future of cerebral protection, and case examples. Register today! https://t.co/kSQlTiOBo4

[Jessica Coates @Jessica_BSCI]

Have you heard of the @TheBHF's PROTECT TAVI study? With the #ProtectedTAVR trial completed, many are asking "What's next?"

We're looking forward to the ~7,730 pt study and meta-analysis with Protected TAVR in the future.
#bhfprotecttavi #cep #tavr #strokeprevention

[BHF PROTECT-TAVI @bhfprotect_tavi]

Congratulations to PROTECTED TAVR #TCT2022. #BHFPROTECTTAVI’s response: #TAVR #TAVI

[Jessica Coates @Jessica_BSCI]

EXCELLENT webinar on interpreting PROTECTED TAVR data & addressing the role of CEP in lifetime patient management with #SENTINEL
@CuissetDr @Mo_A_W @BSCCardiology
#protectedtavr #TCT2022 #CEP
PROTECTED TAVR – Impact on Clinical Practice via @PCRonline https://t.co/4ZLjOTjdVF

[BostonSci Cardiology @BSCCardiology]

#TCT2022 – Head to the Boston Scientific Engagement Hub: your one-stop shop for can’t-miss expert discussions on the latest in #LAAC, #TAVR, #Calcified CAD, #IVUS & #transseptal Access Solutions, and more. See you there! https://t.co/mRVvmb1F09

[Michael O'Riordan @mpjORIORDAN]

The vibe in the late-breaking science session #TCT2022 is that PROTECTED TAVR was a win for embolic protection, even though the trial's primary endpoint was negative. Every panelist said they'd want embolic protection used for a family member.

[Pablo González @Peibol72]

Protected-TAVR Study: 7 out of 8 panelists voted YES for Sentinel use in TAVR procedures to prevent disabling stroke based on study results #CEP @shci_sec

[BostonSci Cardiology @BSCCardiology]

#TCT2022 NEW from the #PROTECTEDTAVR Study: Results show a 60% relative risk reduction in disabling stroke through 72 hours post #TAVR procedure with the use of SENTINEL™ CPS. See the data: https://t.co/PaLdtYuKqz

[Thomas Waggoner @DrTomWaggoner]

Pivotal Late-breaker SHD trial data is to be presented live at TCT in Boston Sept 17th. We are proud to have finished #2 in US enrollment in Protected TAVR and also did well in CLADP 2D! Don’t miss these. Mark your calendar!@TCTMD @crfheart @MartyMleon @KapadiaSamir @TAVRBot

[Jessica Coates @Jessica_BSCI]

ACURATEneo2 improvements shine in the NEOPRO2 Registry, check it out!

@EuroInterventio https://t.co/17TNnVxMpA

[Jessica Coates @Jessica_BSCI]

TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device https://t.co/wFltseaBmx

[BostonSci Cardiology @BSCCardiology]

SENTINEL™ Cerebral Protection System Safety info: https://t.co/GJIRbQCLrY

[BostonSci Cardiology @BSCCardiology]

Any #stroke during #TAVR can be devastating. Even minor cognitive events can result in significant negative consequences on a patient’s quality of life.
Leading into #WorldStrokeDay, see more reasons why physicians practice #ProtectedTAVR: https://t.co/SdiMJhmv4d